Publicacións en colaboración con investigadores/as de Medical University of Vienna (2)

2024

  1. Feasibility of Indirect Treatment Comparisons Between Niraparib Plus Abiraterone Acetate and Other First-Line Poly ADP-Ribose Polymerase Inhibitor Treatment Regimens for Patients with BRCA1/2 Mutation-Positive Metastatic Castration-Resistant Prostate Cancer

    Advances in Therapy

2022

  1. Role of the E3 ubiquitin-ligase Hakai in intestinal inflammation and cancer bowel disease

    Scientific Reports, Vol. 12, Núm. 1